Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Biochemical response is an important prognostic indicator in chronic hepatitis B (CHB) patients receiving nucleotide/nucleoside analogues (NAs). However, the effects of air pollution in alanine aminotransferase (ALT) normalization remain elusive. This longitudinal study recruited 80 hepatitis B e antigen-negative CHB patients who received NAs. ALT levels were measured during the first year of anti-hepatitis B virus therapy. Normal ALT levels were defined as <19 U/L for females and <30 U/L for males, and the risk factors associated with ALT abnormalities were analyzed. The daily estimations of air pollutants (particulate matter ≤2.5 µm in diameter (PM2.5), nitrogen dioxide, ozone (O3), and benzene) were aggregated into the mean estimation for the previous month based on the date of recruitment (baseline) and 1 year later. Sixteen patients (20.0%) had a baseline ALT > 40 U/L; overall, 41 (51.6%) had an abnormal ALT (≥19 U/L for females and ≥ 30 U/L for males). After 1 year of NA therapy, 75 patients (93.8%) had undetectable hepatitis B virus DNA levels. Mean post-treatment ALT levels were significantly lower than mean pretreatment levels (21.3 vs 30.0 U/L, respectively; P < .001). The proportion of patients with a normal ALT was also significantly higher after versus before treatment (71.2% vs 51.2%, respectively; P = .001). The strongest factors associated with ALT abnormality after 1 year of NA treatment were body mass index (odds ratio [OR], 1.28; 95% confidence interval [CI], 1.05-1.54; P = .01) and ozone level (OR, 1.11; 95% CI, 1.02-1.22; P = .02). Among hepatitis B e antigen-negative CHB patients with relatively low viral loads, 1 year of NA treatment improved ALT levels after the adjustment for confounding factors and increased the proportion of patients with normal ALT levels. Air pollution affects the efficacy of ALT normalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“treatment for Hepatitis B viral infection, the leading cause of liver cirrhosis and liver cancer, may be adversely affected by air pollution”
From Is Pollution the Primary Driver of Infectious Syndemics? (2024) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Choi, J., Kim, H. J., Lee, J., Cho, S., Ko, M. J., & Lim, Y.-S. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4070 · Cited by 282 · cited 1×
“[30] Some hepatolo-gists suggest NA therapy only if HBV DNA is more than 2000 IU/mL. [31] It has been controversial whether patients need NAs if HBV DNA is less than 2000 IU/mL in non-cirrhotic patients.”
RetractedEASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140 · cited 1×
“[23] However, it is a dynamic phase that can reactivate to an immune-active phase.”
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110 · cited 1×
“[16] Liver cirrhosis was diagnosed by the presence of laboratory, radiological, endoscopic, or clinical evidence of portal hypertension and/or cirrhosis.”
AASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2016) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,006 · cited 1×
“[5] .”
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
Hsu, Y.-S., Chien, R.-N., Yeh, C.-T., Sheen, I.-S., Chiou, H.-Y., Chu, C.-M., & Liaw, Y.-F. (2002) · Hepatology · doi:10.1053/jhep.2002.33638 · Cited by 705
Buti, M., Gane, E., Seto, W. K., Chan, H. L. Y., Chuang, W.-L., Stepanova, T., Hui, A.-J., Lim, Y.-S., Mehta, R., Janssen, H. L. A., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30107-8 · Cited by 554 · cited 1×
“[9] Meanwhile, early ALT normalization after NA therapy has been associated with fewer hepatic complications and a lower HCC incidence.”
Guidelines on the management of abnormal liver blood tests
Newsome, P. N., Cramb, R., Davison, S. M., Dillon, J. F., Foulerton, M., Godfrey, E. M., Hall, R., Harrower, U., Hudson, M., Langford, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314924 · Cited by 535 · cited 1×
“[21,35,36] Some studies suggest body weight gain after NA treatment.”
Chu, C., & Liaw, Y. (2007) · Hepatology · doi:10.1002/hep.21612 · Cited by 348 · cited 1×
“[25] Some studies suggested that peginterferon could increase the HBsAg loss rate, while other studies failed to prove this.”
Cited by
Jang, T., Ho, C.-C., Wu, C., Dai, C., & Chen, P. (2024) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001053 · Cited by 12
“31,32 Globally, approximately 70 million people are infected with HCV. 6 Patients with chronic HCV infection may develop HCC and liver-related complications.”
BackgroundJang, T., Zeng, Y., Liang, P., Wu, C., Wei, Y., Tsai, P., Hsu, P., Hsieh, M., Lin, Y., Hsieh, M., et al. (2024) · Liver International · doi:10.1111/liv.16149 · Cited by 14
“Our previous study demonstrated that air pollution impeded biomedical normalisation in CHB patients treated with NAs [8].”
Is Pollution the Primary Driver of Infectious Syndemics?
Singer, M. (2024) · Pathogens · doi:10.3390/pathogens13050370 · Cited by 8
“Moreover, treatment for Hepatitis B viral infection, the leading cause of liver cirrhosis and liver cancer, may be adversely affected by air pollution [31].”
BackgroundJang, T., Zeng, Y., Liang, P., Wu, C., Wei, Y., Tsai, P., Hsieh, M., Lin, Y., Hsieh, M., Wang, C., et al. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70019 · Cited by 5
“Other details of the air pollutant assessment have been described in our previous studies [12–14].”
Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
Jang, T., Batsaikhan, B., Chen, Y.-C., & Dai, C. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16667 · Cited by 3
“6,16 The natural history of CHB included fi ve clinical phases.”
Metadata
- Authors
- Jang, T.-Y., Ho, C.-C., Wu, C.-D., Dai, C.-Y., & Chen, P.-C.
- Affiliations
- Kaohsiung Medical University (TW)
- National Taiwan University (TW)
- National Chung Hsing University (TW)
- National Health Research Institutes (TW)
- Corresponding author
- Dai, Chia-Yen
- Venue
- Medicine
- Published
- 2023-10-27
- Volume
- 102
- Issue
- 43
- Pages
- e34276
- ISSN
- 0025-7974 (ISSN-L)
- 1536-5964
- PMC
- PMC10615411
- OpenAlex
- W4388033359
- Cited by
- 10
- References
- 39
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Kaohsiung Medical University
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- National Science and Technology Council
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Air Quality and Health Impacts
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- air pollution, chronic hepatitis B, alanine aminotransferase normalization, ozone, particulate matter, nitrogen dioxide, benzene, body mass index, antiviral efficacy, environmental exposure
- MeSH terms
- Air Pollution, Alanine Transaminase, Antiviral Agents, DNA, Viral, Female, Hepatitis B e Antigens, Hepatitis B virus, Humans, Longitudinal Studies, Male, Nucleosides, Nucleotides, Ozone, Hepatitis B, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues. https://app.cochat.ai/papers/10.1097/md.0000000000034276
- The paper
- Jang, T.-Y., Ho, C.-C., Wu, C.-D., Dai, C.-Y., & Chen, P.-C. (2023). Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues. Medicine. https://doi.org/10.1097/md.0000000000034276
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
